Click on the session headers to view the speakers’ learning objectives and biographies.
08:00 – 08:30
08:45
Join Symposium Mammographicum Online
09:00 – 10:00
Chair: Claire Borrelli, Symposium Mammographicum Organising Committee
SMALL – Mr Stuart McIntosh, Clinical Senior Lecturer in Surgical Oncology, Queen’s University Belfast
LORIS and Nostra trial where we are – Dr Matthew Wallis, Consultant Radiologist, Cambridge
Panel discussion
10:00 – 11:00
Chair: Claire Borrelli, Symposium Mammographicum Organising Committee
Telephone results study – Dr Sian Taylor-Phillips, Associate Professor of Screening and Test Evaluation, Warwick Medical School
Genetics App SGH – Dr Katie Snape, Consultant Cancer Geneticist, St George’s Hospital
How do women experience a false positive test result from breast screening? A systematic review and thematic synthesis – Miss Hannah Long, PhD student, University of Manchester
Panel discussion
11:00 – 11:30
11:30 – 11:40
Comfort break
11:40 – 13:10
Chair: Mr Oliver Morrish, Symposium Mammographicum Organising Committee
QA testing for CESM – Ms Katherine Schofield, Mammography Physics Team, Health Facilities Scotland
Towards the model observer – Dr Lynn Martinez, Clinical Scientist, Royal Free
Dose management and practical implications – Mr Matthew Dunn, Head of Radiation Physics, Nottingham University Hospitals NHS Trust
Breast imaging dosimetry: Present and future – Dr Ioannis Sechopoulos, Associate Professor, Radboud University Medical Centre, LRCB, Dutch Expert Centre for Screening
Panel discussion
13:10 – 14:00
Lunch break and Hologic Sponsor’s symposium
13:10 – 14:00
Improving performance in tomosynthesis through Artificial Intelligence and SmartSlices – Sue Branfield, Hologic®
Tomosynthesis within breast imaging – benefits and challenges – Dr Nisha Sharma , Director of Breast Screening and Clinical Lead for Breast Imaging, Leeds Teaching Hospitals NHS Trust
3DQuorumTM in the Symptomatic Breast Unit – Anne Neilson-Moody, Consultant Radiographer, Leeds St James’s Hospital
14:00 – 15:10
Chair: Mrs Claire Borrelli, Symposium Mammographicum Organising Committee
Breast cancer as a chronic disease – Professor Debbie Fenlon, Professor of Nursing, Swansea University
Imaging metastatic disease/PET – Professor Iain Lyburn, Gloucestershire Hospitals NHSFT
Pathology of primary and recurrent/metastatic tumours – informing the decision to rebiopsy – Dr Rahul Deb, Consultant Histopathologist & Breast MDT Lead, University Hospitals of Derby and Burton
Oncologist’s view – how to broach bad news regarding secondary breast cancer – Dr Muireann Kelleher, Oncologist, St George’s University Hospitals NHS Foundation Trust
Panel discussion
15:10 – 15:40
15:40 – 16:10
Comfort break and poster viewing – click here to view the poster showcase
16:10 – 17:00
Chair: Ms Patsy Whelehan, Symposium Mammographicum Organising Committee
Estimating the cost impact of including Magnetic Resonance Imaging (MRI) in the National Health Service Breast Screening Programme (NHSBSP) for population-risk women in England – Professor Claire Hulme, University of Exeter
Expression of the gadolinium transporters SLCO1B1 and SLCO1B3 in breast cancers: A potential role in influencing tumour enhancement on MRI – Rachel Sutherland, Newcastle University
Determination of onset fatigue while reading Digital Breast Tomosynthesis (DBT) cases – Mitchell Searjeant, University of Nottingham
Q&A
17:00 – 18:00
Poster viewing – click here to view the poster showcase
18:15 – 18:45
